Breaking News

SNBL USA Appoints Field Technical Director

June 28, 2013

Templin to provide scientific, regulatory guidance for preclinical programs

Michael Templin, Ph.D., DABT, has been named field technical director for SNBL USA.  Dr. Templin, based on the west coast, will work closely with business development and internal scientific teams to provide SNBL USA’s clients with scientific and regulatory guidance to support their preclinical development programs. He joins the company from Marina Biotech where he served as chief technology officer.
 
Dr. Templin is a board-certified toxicologist with more than 15 years of experience in preclinical and early clinical drug development. He has extensive experience in small molecules, biologics, peptides and multiple classes of nucleic acid-based drugs, and has worked in multiple therapeutic areas including cancer, inflammation, cardiovascular, metabolic and antivirals. He also has experience with nonhuman primate programs, including design, oversight and interpretation of research and GLP studies for INDs, NDAs and ex-U.S. submissions.
 
“This is an exciting time for SNBL USA and our clients,” said Mark Crane, vice president of business development. “Dr. Templin’s exceptional preclinical and early clinical background, along with his technical expertise and outstanding communication skills, will significantly enhance the benefits in working with SNBL USA.

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016